72 related articles for article (PubMed ID: 3723170)
21. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer].
Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1986; 107(4):193-9. PubMed ID: 3467641
[No Abstract] [Full Text] [Related]
22. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
[No Abstract] [Full Text] [Related]
23. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients.
Lian LJ; Hu XF; Liu WS; Wu AJ
Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106
[No Abstract] [Full Text] [Related]
24. [Significance of a new tumor marker for breast carcinoma and ovarian carcinoma].
Hoffmann L
Dtsch Med Wochenschr; 1987 May; 112(21):847-9. PubMed ID: 3472869
[No Abstract] [Full Text] [Related]
25. [Tumor markers in epithelial carcinoma of the ovary].
Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
[No Abstract] [Full Text] [Related]
26. Initial immunochemical characterization of MX35 ovarian cancer antigen.
Welshinger M; Yin BW; Lloyd KO
Gynecol Oncol; 1997 Nov; 67(2):188-92. PubMed ID: 9367706
[TBL] [Abstract][Full Text] [Related]
27. [Radioimmunological determination of cancerocerebral antigen in the blood serum of patients with ovarian tumors].
Griaznova IM; Borisenko SA; Sokolov AV; Prokopenko PG; Makarov OV
Akush Ginekol (Mosk); 1984 Apr; (4):27-9. PubMed ID: 6204548
[No Abstract] [Full Text] [Related]
28. Clinical correlations of ovarian cancer antigen NB/70K: a preliminary report.
Dembo AJ; Chang PL; Urbach GI
Obstet Gynecol; 1985 May; 65(5):710-4. PubMed ID: 3856794
[TBL] [Abstract][Full Text] [Related]
29. [Immunology of malignant ovarian tumors. I. Familial occurrence, antigens and specific immunity].
Markowska J
Ginekol Pol; 1984 Sep; 55(9):695-700. PubMed ID: 6398791
[No Abstract] [Full Text] [Related]
30. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
31. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of CA125 as a circulating tumor marker for ovarian cancer.
Kuzuya K; Nozaki M; Chihara T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):949-57. PubMed ID: 3461071
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
Bhattacharya M; Barlow JJ; Chu TM; Piver MS
Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
[No Abstract] [Full Text] [Related]
34. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
[No Abstract] [Full Text] [Related]
35. Ovarian tumor antigens.
Benson MD; Lurain JR; Newton M
J Reprod Med; 1983 Jan; 28(1):17-23. PubMed ID: 6187917
[TBL] [Abstract][Full Text] [Related]
36. [Distribution of one of the ascitic fluid antigens of ovarian cancer patients in malignant tumors of the stomach and intestines].
Sergeeva NS; Vasil'ev MIu; Kovalenko TI; Sokolova NV; Avdeev GI
Eksp Onkol; 1989; 11(2):35-7. PubMed ID: 2661204
[TBL] [Abstract][Full Text] [Related]
37. CA-125: An evaluation.
Nuss R; Swor MG; Benrubi MD
J Fla Med Assoc; 1987 May; 74(5):329-32. PubMed ID: 2440975
[No Abstract] [Full Text] [Related]
38. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.
Ricolleau G; Chatal JF; Fumoleau P; Kremer M; Douillard JY; Curtet C
Tumour Biol; 1984; 5(3-4):151-9. PubMed ID: 6594738
[TBL] [Abstract][Full Text] [Related]
39. Cross-specificity of the tumour marker CA 19-9: a case of ovarian carcinoma with recurrent venous thrombosis.
Smellie S; Lambert M
Acta Gastroenterol Belg; 1987; 50(2):241-2. PubMed ID: 3481507
[No Abstract] [Full Text] [Related]
40. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]